Deciphering nodal burden in thyroid carcinoma: A dedicated survey of age, lymph node ratio, log odds of positive nodes, and preoperative prediction models
Open Access
- 27 March 2026
- journal article
- review article
- Published by Wiley in Journal of Intelligent Medicine
- Vol. 3 (2) , 169-191
Abstract
Evidence regarding the prognosis of thyroid carcinoma is heterogeneous, ranging from age effects and nodal burden metrics, such as lymph node ratio (LNR) and log odds of positive nodes (LODDS), to preoperative imaging models comprising ultrasound, CEUS, and radiomics. We conducted a systematic review in line with PRISMA 2020 and SWiM, tabulated under four domains: age relative to the American Joint Committee on Cancer (AJCC‐8) staging system, LNR and LODDS, and preoperative prediction models. Terminology and units were standardized through dual data extraction and Python‐based harmonization. Prognostic studies were evaluated by Quality in Prognosis Studies, and prediction models were assessed using PROBAST. The AJCC‐8 55‐year threshold remains pragmatically useful, yet continuous nonlinear modeling of age offers better support for individualized risk estimates. Supplementing anatomic N staging with LNR significantly enhances prognostication, with compartment‐specific ratios refining the N1 subgroup. LODDS should be coreported with LNR because it is less sensitive to lymph‐node yield, preserves information at extreme values, and often equals or outperforms LNR. Preoperative radiomics and nomograms are promising but often lack external validation and adequate calibration, limiting clinical readiness. Common limitations include endpoint heterogeneity, variable follow‐up, node‐yield dependency, and sparse reporting of calibration or decision‐curve analysis. Residual confounding in retrospective cohorts and reporting bias remain significant challenges.Keywords
This publication has 22 references indexed in Scilit:
- Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective StudyEndocrine Practice, 2023
- Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid CancerThyroid®, 2021
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- Impacts of the American Joint Committee on Cancer (AJCC) 8th edition tumor, node, metastasis (TNM) staging system on outcomes of differentiated thyroid cancer in Thai patientsHeliyon, 2021
- The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based PhenotypingRadiology, 2020
- Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guidelineBMJ, 2020
- Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid CarcinomaThyroid®, 2019
- Radiomics: the bridge between medical imaging and personalized medicineNature Reviews Clinical Oncology, 2017
- An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid CancerThyroid®, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016